Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes

被引：0
|
作者：
Lim, S. [1 ]
Min, K. [2 ]
Yu, J. -M. [3 ]
Chamnan, P. [4 ]
Kim, E. [5 ,13 ]
Yoon, K. -H. [6 ]
Kwon, S. [7 ]
Moon, M. [8 ]
Lee, K. [9 ]
Kim, D. -J. [10 ]
Kim, M. [11 ]
Wongtanate, M. [12 ]
Kim, E. [5 ,13 ]
Kim, S. -H. [13 ]
Lee, M. -K. [14 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea
[2] Eulji Univ, Med Ctr, Seoul, South Korea
[3] Kangnam Sacred Heart Hosp, Seoul, South Korea
[4] Sunpasitthiprasong Hosp, Ubon Ratchathani, Thailand
[5] Ulsan Univ Hosp, Ulsan, South Korea
[6] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea
[7] Samsung Changwon Hosp, Chang Won, South Korea
[8] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea
[9] Ajou Univ Hosp, Suwon, South Korea
[10] Inje Univ, Ilsan Paik Hosp, Goyang, South Korea
[11] Inje Univ, Haeundae Paik Hosp, Busan, South Korea
[12] Nan Hosp, Nan, Thailand
[13] LG Life Sci, Seoul, South Korea
[14] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
109
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] Effects of gemigliptin versus sitagliptin or glimepiride on glycaemic variability as initial combination therapy with metformin in drug-naive patients with type 2 diabetes
    Lee, B. -W.
    Kim, J.
    Park, S.
    Jung, C.
    Lee, S. -H.
    Suh, S.
    Lee, W.
    Cho, J. -H.
    Jang, Y.
    Kim, S. -H.
    Park, C. -Y.
    DIABETOLOGIA, 2015, 58 : S387 - S387
  • [2] EFFECTS OF GEMIGLIPTIN VERSUS SITAGLIPTIN OR GLIMEPIRIDE ON GLYCEMIC VARIABILITY AS INITIAL COMBINATION THERAPY WITH METFORMIN IN DRUG-NAIVE PATIENTS WITH TYPE 2 DIABETES
    Park, S. E.
    Lee, B. -W.
    Kim, J. H.
    Jung, C. H.
    Lee, S. -H.
    Suh, S. H.
    Lee, W. J.
    Jang, Y. H.
    Kim, S. -H.
    Park, C. -Y.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S139 - S139
  • [3] Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naive Type 2 Diabetes
    Rosenstock, Julio
    Chuck, Leonard
    Gonzalez-Ortiz, Manuel
    Merton, Kate
    Craig, Jagriti
    Capuano, George
    Qiu, Rong
    DIABETES CARE, 2016, 39 (03) : 353 - 362
  • [4] Initial combination therapy with saxagliptin and metformin improves glycaemic control compared with either monotherapy alone in drug-naive patients with type 2 diabetes
    Chen, R.
    Pfuetzner, A.
    Jadzinsky, M.
    Paz-Pacheco, E.
    Xu, Z.
    Allen, E.
    DIABETOLOGIA, 2008, 51 : S38 - S38
  • [5] Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naive patients with type 2 diabetes: a randomized, double-blind, 6-month study
    Pratley, R. E.
    Fleck, P.
    Wilson, C.
    DIABETES OBESITY & METABOLISM, 2014, 16 (07): : 613 - 621
  • [6] Efficacy and safety of linagliptin/metformin fixed-dose combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Gong, Y.
    Mu, Y.
    Fan, B.
    Hehnke, U.
    Pan, C.
    DIABETOLOGIA, 2015, 58 : S388 - S388
  • [7] Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Mu, Yiming
    Pan, Changyu
    Fan, Bei
    Hehnke, Uwe
    Zhang, Xiuzhen
    Zhang, Xuejun
    Wang, Xiaoyue
    Liu, Jingdong
    Zhang, Ying
    Du, Jianling
    Ma, Jianhua
    Gong, Yan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 124 : 48 - 56
  • [8] Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study)
    Lim, Soo
    Han, Kyung Ah
    Yu, JaeMyung
    Chamnan, Parinya
    Kim, Eun Sook
    Yoon, Kun-Ho
    Kwon, Sam
    Moon, Min Kyong
    Lee, Kwan Woo
    Kim, Dong-Jun
    Kim, Mikyung
    Wongtanate, Manaj
    Kim, Eun Young
    Kim, Sung-Ho
    Lee, Moon-Kyu
    DIABETES OBESITY & METABOLISM, 2017, 19 (01): : 87 - 97
  • [9] Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Lobeglitazone in Drug-Naive Patients with Type 2 Diabetes
    Kim, Kyoung Min
    Lee, Seo Young
    Lee, Ji Hyun
    Lee, Dong Hwa
    Oh, Tae Jung
    Jang, Hak Chul
    Lim, Soo
    DIABETES, 2017, 66 : A346 - A346
  • [10] Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients with Type 2 Diabetes
    Cuddihy, Robert M.
    Russell-Jones, David
    Hanefeld, Markolf
    Kumar, Ajay
    Gonzalez, Jose G.
    de Teresa, Luis
    Boardman, Marilyn
    Chan, Melanie
    Wolka, Anne M.
    Porter, Lisa
    DIABETES, 2011, 60 : A77 - A77
12345